Health In Tech, Inc. (HIT) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-254.8%

-$0.91

vs $0.58 price

Levered DCF

$0.17

After debt service

Piotroski score

0 / 9

Weak

Altman Z-score

2.63

Grey zone

Rating

B-

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022
P/E	79.5×	435.77×	111.35×	3,400×
P/B	5.19×	21.84×	45.26×	262.49×
P/S	2.66×	14.76×	14.4×	47.79×
EV / EBITDA	31.56×	145.44×	73.14×	1,335.63×
Gross margin	62.8%	79.2%	88.0%	94.2%
Operating margin	4.6%	5.1%	17.7%	3.6%
Net margin	3.8%	3.4%	12.9%	1.4%
Current ratio	3.13×	5.06×	1.43×	1.06×
Debt / equity	0.01×	0.02×	0.31×	0.3×
Interest coverage	0×	2×	1,648.68×	44.97×
Dividend yield	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022
Return on equity	7.5%	5.1%	40.6%	7.6%
Return on invested capital	6.5%	5.4%	29.0%	1.8%
Return on assets	5.5%	4.3%	21.5%	0.3%
Free cash flow yield	-0.1%	0.4%	0.1%	-0.2%
Earnings yield	1.4%	0.2%	0.9%	0.0%
Enterprise value	$81.3M	$280M	$275.3M	$274.6M
Net debt / EBITDA	-2.92×	-3.97×	-0.13×	-5.7×
Cash conversion cycle (days)	-68	-127	-341	-456